Rocatinlimab, Placebo for AMG 451
20230053
Phase 3 small_molecule active
Quick answer
Rocatinlimab, Placebo for AMG 451 for Prurigo Nodularis is a Phase 3 program (small_molecule) at Amgen Technology (Ireland) UC with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Amgen Technology (Ireland) UC
- Indication
- Prurigo Nodularis
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- active